2023
DOI: 10.3389/fbioe.2023.1163933
|View full text |Cite
|
Sign up to set email alerts
|

Vancomycin-loaded silk fibroin microspheres in an injectable hydrogel for chronic osteomyelitis therapy

Abstract: Introduction: Chronic osteomyelitis remains a clinical challenge in orthopedics.Methods: In this study, silk fibroin microspheres (SFMPs) loaded with vancomycin are entrapped in an injectable silk hydrogel to form a vancomycin delivery system for treatment of chronic osteomyelitis.Results and Discussion: Vancomycin showed continuous release from the hydrogel for up to 25 days. The hydrogel shows strong antibacterial activity against both Escherichia coli and Staphylococcus aureus and a long antibacterial durat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(2 citation statements)
references
References 33 publications
0
2
0
Order By: Relevance
“…Silk fibroin (SF) is a natural protein isolated from Bombyxmori cocoons 17 . It has been developed into kinds of material forms such as nanofibers, 18,19 microspheres, 20,21 hydrogels, 22,23 membranes, 24,25 and scaffolds 26,27 . The SF‐based hydrogel has good biocompatibility, biodegradability, and low immunogenicity for biomedical applications 28,29 .…”
Section: Introductionmentioning
confidence: 99%
“…Silk fibroin (SF) is a natural protein isolated from Bombyxmori cocoons 17 . It has been developed into kinds of material forms such as nanofibers, 18,19 microspheres, 20,21 hydrogels, 22,23 membranes, 24,25 and scaffolds 26,27 . The SF‐based hydrogel has good biocompatibility, biodegradability, and low immunogenicity for biomedical applications 28,29 .…”
Section: Introductionmentioning
confidence: 99%
“…At present, a large number of antibiotic sustained-release materials have been developed to treat osteomyelitis ( Hasan et al, 2019 ; Xu et al, 2021 ; Feng et al, 2022 ; Gritsch et al, 2022 ; Wu et al, 2022 ), but the treatment effect is still not ideal and the recurrence rate is high. Zhou ( Zhang et al, 2023 ) et al reported Vancomycin-loaded silk fibroin microspheres in an injectable hydrogel for chronic osteomyelitis therapy, demonstrating a sustained-release profile and good biocompatibility, making it promising for application in osteomyelitis treatment. Ju ( Ju et al, 2023 ) reported a novel Zn 2+ incorporated composite polysaccharide microspheres for sustained growth factor release and wound healing.…”
Section: Introductionmentioning
confidence: 99%